RxDoctor Payments DataLook up a doctor →

Fariborz Rezai

Critical Care Medicine · Livingston, NJNPI 1942249313

Payments from drug & device makers

$2,389,838in general payments, 2019–2025

Across 2,575 payments — averaging $928.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$468K
  • CSL Behring$281K
  • Gilead$241K
  • Johnson & Johnson$227K
  • AbbVie$167K
  • Portola Pharmaceuticals, LLC$146K
  • plus $860K from 40 others

What the payments were for

  • Consulting fees$192,2878%
  • Speaking & faculty fees$1,895,40681%
  • Travel & lodging$199,4488%
  • Food & beverage$62,0133%
  • Education$290%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,389,838 in reported general payments places this provider in the 95th percentile of 254 critical care medicine providers in New Jersey.

See all critical care medicine providers in New Jersey

Other critical care medicine in Livingston

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →